A generic alternative indicated for Pain Relief. This medication supports the management of uric acid levels and assists in reducing the frequency of inflammatory joint discomfort.
Designed to mitigate high uric acid levels to alleviate the frequency of gout flares and support long-term joint health in adult patients.
Mechanism of Action
Febuxostat blocks the xanthine oxidase enzyme, which is responsible for creating uric acid in the body. By reducing the production of uric acid, it prevents the formation of crystals in the joints that cause gout attacks.
Route of Administration
Oral
Onset Time
Steady state in 2 weeks
Duration
24 hours
Contraindications
Severe liver impairment, Treatment with azathioprine or mercaptopurine, Severe cardiovascular disease (caution)
Severe Adverse Events
Increased risk of cardiovascular death, Heart attack, Stroke, Severe liver injury, Serious skin reactions (SJS/TEN)
Information for Uloric is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
